FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of biotechnology and virology. Novel recombinant polypeptide of influenza virus, representing haemagglutin, is claimed. Described polypeptide can be used for obtaining novel recombinant reassortant strains of influenza virus. Invention can be used in medicine.
EFFECT: described are: recombinant nucleic acid, coding such polypeptide, method of obtaining reassortant influenza viruses, reassortant influenza virus and thereof-containing compositions.
16 cl, 9 dwg, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
| ISOLATED RECOMBINANT VIRUS BASED ON INFLUENZA VIRUS FOR INDUCING SPECIFIC IMMUNITY TO INFLUENZA VIRUS AND/OR PREVENTING DISEASES CAUSED BY INFLUENZA VIRUS | 2021 |
|
RU2813150C2 |
| INFLUENZA HEMAGGLUTININ COMPOSITIONS WITH HETEROLOGOUS EPITOPES AND/OR ALTERED CLEAVAGE SITES DURING MATURATION | 2017 |
|
RU2769406C2 |
| VACCINE TO SWINE INFLUENZA A VIRUS | 2018 |
|
RU2787596C2 |
| NEUTRALIZING ANTIBODIES TO INFLUENZA VIRUS B AND WAYS OF THEIR APPLICATION | 2015 |
|
RU2739952C2 |
| AFRICAN SWINE FEVER VACCINE | 2020 |
|
RU2819672C2 |
| NEUTRALIZING ANTIBODIES AGAINST THE INFLUENZA A VIRUS AND WAYS OF THEIR APPLICATION | 2014 |
|
RU2803850C2 |
| NEUTRALISING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF | 2014 |
|
RU2683498C2 |
| NEUTRALIZING ANTIBODIES TO INFLUENZA B VIRUS AND THEIR APPLICATION METHODS | 2020 |
|
RU2784915C2 |
| STRAIN OF A RECOMBINANT PSEUDO ADENOVIRAL PARTICLE BASED ON HUMAN ADENOVIRUS GENOME OF SEROTYPE 5 Ad5-tetOFF-E3-HA125 SEROTYPE, CARRYING HAEMAGGLUTININ CONSENSUS GENE OF INFLUENZA VIRUS SUBTYPES H1, H2, H5 FOR PRODUCING INFLUENZA IMMUNOGENIC PREPARATIONS, METHOD FOR PRODUCING GENE | 2018 |
|
RU2713722C1 |
